1. Home
  2. KPRX vs ECDA Comparison

KPRX vs ECDA Comparison

Compare KPRX & ECDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kiora Pharmaceuticals Inc.

KPRX

Kiora Pharmaceuticals Inc.

N/A

Current Price

$2.14

Market Cap

9.2M

Sector

Health Care

ML Signal

N/A

Logo ECD Automotive Design Inc.

ECDA

ECD Automotive Design Inc.

HOLD

Current Price

$0.30

Market Cap

926.4K

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPRX
ECDA
Founded
1998
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
926.4K
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KPRX
ECDA
Price
$2.14
$0.30
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
52.2K
765.9K
Earning Date
11-07-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$24,501,965.00
Revenue This Year
N/A
$21.59
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.77
$0.30
52 Week High
$4.18
$42.80

Technical Indicators

Market Signals
Indicator
KPRX
ECDA
Relative Strength Index (RSI) 51.31 23.75
Support Level $2.00 $0.33
Resistance Level $2.17 $0.46
Average True Range (ATR) 0.13 0.06
MACD 0.04 0.05
Stochastic Oscillator 95.07 1.97

Price Performance

Historical Comparison
KPRX
ECDA

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

About ECDA ECD Automotive Design Inc.

ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the majority customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.

Share on Social Networks: